Bluejay Diagnostics, Inc.
BJDXNASDAQHealthcareMedical Devices

About Bluejay Diagnostics

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. Further, it is developing additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Company Information

CEOIndranil Dey
Founded2015
IPO DateNovember 10, 2021
Employees7
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone844 327 7078
Address
360 Massachusetts Avenue, Suite 203 Acton, Massachusetts 01720 United States

Corporate Identifiers

CIK0001704287
CUSIP095633103
ISINUS0956335097
EIN47-3552922
SIC3841

Leadership Team & Key Executives

Indranil Dey
Principal Financial, Accounting and Executive Officer, President, Chief Executive Officer and Director
Kevin Vance
Chief Commercial Officer
Mark W. Feinberg M.D., Ph.D.
Chief Medical Advisor
Dr. Mark W. Feinberg M.D.
Chief Medical Advisor